Investing

Blueprint Medicines : BPMC

BPMC

Stock Data

$129.46

$0.00 (0.00%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Blueprint Medicines Corp is a pioneer in developing targeted therapies for cancer and blood disorders. With a focus on precision medicine, they are advancing a pipeline of innovative treatments, including AYVAKIT for systemic mastocytosis and gastrointestinal tumors, and GAVRETO for certain types of lung and thyroid cancers. Their research also extends to tackling lung cancer with novel inhibitors and addressing rare conditions like fibrodysplasia ossificans progressive. Based in Cambridge, Massachusetts, Blueprint Medicines is committed to transforming patient outcomes through groundbreaking science.

All Blueprint Medicines Articles

10 Articles

Lee Jackson | Jun 6, 2023 at 8:55 AM EDT

Tuesday’s Top Analyst Upgrades and Downgrades: Aflac, Comerica, Costco, Dollar General, Dominion Energy, Ford, Meta, T-Mobile, Walmart and More

Tuesday's top analyst upgrades and downgrades included Aflac, Cloudflare, Comerica, Comstock Resources, Costco Wholesale, Dollar General, Dominion Energy, Equitrans Midstream,…

Lee Jackson | Aug 23, 2022 at 8:51 AM EDT

Tuesday’s Top Analyst Upgrades and Downgrades: Boeing, ChargePoint, Deere, Foot Locker, Salesforce, UPS, Vipshop, Walmart and More 

Tuesday’s top analyst upgrades and downgrades included Boeing, Boston Scientific, ChargePoint, Deere, Foot Locker, Horizon Therapeutics, Nu, Ross Stores, Salesforce,…

Chris Lange | Jun 29, 2022 at 9:25 AM EDT

Wells Fargo Cuts Targets and Coverage on Carnival and More

Wells Fargo issues a few calls and warns investors that these stocks could underperform the markets, even considering the bear…

Lee Jackson | Jun 13, 2022 at 8:43 AM EDT

Monday’s Top Analyst Upgrades and Downgrades: Electronic Arts, Enterprise Products Partners, GoodRx, Netflix, Spirit Airlines, Take-Two Interactive, Target, Tesla and More

Monday's top analyst upgrades and downgrades included Docusign, Electronic Arts, Enterprise Products Partners, GoodRx, Netflix, Spirit Airlines, Take-Two Interactive Software,…

Chris Lange | Jun 1, 2022 at 11:25 AM EDT

New Month, Renewed Optimism? Analysts Upgrade or Downgrade eBay, Infosys, Valero Energy and More

Wednesday’s additional top analyst upgrades and downgrades were on Danaher, eBay, GoodRx, Infosys, Valero Energy, Xylem and more.

Chris Lange | Feb 17, 2022 at 4:20 PM EST

Thursday Afternoon’s Top Analyst Upgrades and Downgrades: Autodesk, Check Point Software, DoorDash, Hilton, Nvidia, Upstart and More

Thursday afternoon's top analyst upgrades and downgrades included Autodesk, Check Point Software, DoorDash, Hilton, Nvidia, Upstart and more.

Lee Jackson | Mar 31, 2021 at 8:43 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Applied Materials, BP, Bumble, Carrier, Harley-Davidson, Hess, Illumina, Johnson Controls and More

Wednesday's top analyst upgrades and downgrades included Apple, Applied Materials, BP, Bumble, Carrier, Harley-Davidson, Hess, Illumina, Johnson Controls and Lennar.

Jon C. Ogg | Nov 2, 2020 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, Alibaba, ADM, Best Buy, Intel, Lemonade, Nikola, Peloton, SAP, Under Armour, Wynn and More

Monday's top analyst upgrades and downgrades included AbbVie, Alibaba, Archer Daniels Midland, Best Buy, Intel, Nikola, Peloton Interactive, SAP, Under…

Chris Lange | Jul 14, 2020 at 11:42 AM EDT

What Does $1.7 Billion Mean to Blueprint Medicines?

Blueprint Medicines announced early on Tuesday that it had entered into a global collaboration with pharmaceutical giant Roche in which…

Jon C. Ogg | Mar 24, 2020 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: AMD, Alcoa, Biomarin, Coca-Cola, Ford, GM, Intel, Kinder Morgan, Micron, Nvidia, Tesla, Twitter, Zillow and More

Tuesday's top analyst calls included Advanced Micro Devices, Alcoa, Biomarin Pharmaceutical, Coca-Cola, Ford, General Motors, Intel, Kinder Morgan, Micron Technology,…